Total Payments
$16,281
2024 Payments
$3,277
Companies
31
Transactions
947
Medicare Patients
4,920
Medicare Billing
$237,268
Payment Breakdown by Category
Food & Beverage$15,704 (96.5%)
Education$577.70 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,704 | 939 | 96.5% |
| Education | $577.70 | 8 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,009 | 146 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,444 | 66 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,345 | 51 | $0 (2024) |
| Janssen Biotech, Inc. | $1,140 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $984.14 | 62 | $0 (2024) |
| Amgen Inc. | $942.53 | 46 | $0 (2024) |
| Dermavant Sciences, Inc. | $736.23 | 31 | $0 (2024) |
| UCB, Inc. | $723.48 | 33 | $0 (2024) |
| Incyte Corporation | $706.59 | 36 | $0 (2024) |
| MAYNE PHARMA INC. | $688.84 | 87 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,277 | 167 | ABBVIE INC. ($525.00) |
| 2023 | $5,298 | 310 | MAYNE PHARMA COMMERCIAL LLC ($622.22) |
| 2022 | $4,055 | 257 | ABBVIE INC. ($513.88) |
| 2021 | $3,651 | 213 | AbbVie Inc. ($554.25) |
All Payment Transactions
947 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 12/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Inflammation & Immunology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Immunology | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,460 | 2,392 | $191,800 | $79,084 |
| 2022 | 11 | 1,293 | 2,035 | $161,381 | $64,059 |
| 2021 | 11 | 1,187 | 2,001 | $140,806 | $55,069 |
| 2020 | 10 | 980 | 1,528 | $109,296 | $39,056 |
Total Patients
4,920
Total Services
7,956
Medicare Billing
$237,268
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 342 | $44,118 | $23,719 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 270 | 315 | $31,500 | $15,422 | 49.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 170 | 203 | $28,420 | $12,836 | 45.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 267 | 346 | $36,330 | $10,160 | 28.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 139 | 156 | $21,684 | $7,947 | 36.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 195 | 846 | $15,228 | $3,241 | 21.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 75 | $4,875 | $2,244 | 46.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 17 | 26 | $4,160 | $1,832 | 44.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 39 | $2,925 | $1,170 | 40.0% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 12 | $1,920 | $486.40 | 25.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 32 | $640.00 | $25.86 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 214 | 252 | $32,508 | $16,341 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 250 | 281 | $28,100 | $13,372 | 47.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 152 | 176 | $24,640 | $10,727 | 43.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 222 | 274 | $28,770 | $8,189 | 28.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 136 | 146 | $20,294 | $7,251 | 35.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 166 | 710 | $12,780 | $2,721 | 21.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 90 | 94 | $6,110 | $2,649 | 43.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,364 | $1,067 | 45.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 11 | $2,750 | $934.74 | 34.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 25 | 27 | $2,025 | $780.62 | 38.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 52 | $1,040 | $26.81 | 2.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 199 | 224 | $22,270 | $11,715 | 52.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 123 | 147 | $20,580 | $8,893 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 130 | $16,770 | $8,696 | 51.9% |
About Devon Driver, FNP-BC
Devon Driver, FNP-BC is a Family healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821432899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devon Driver, FNP-BC has received a total of $16,281 in payments from pharmaceutical and medical device companies, with $3,277 received in 2024. These payments were reported across 947 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($15,704).
As a Medicare-enrolled provider, Driver has provided services to 4,920 Medicare beneficiaries, totaling 7,956 services with total Medicare billing of $237,268. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Columbia, SC
- Active Since 04/22/2013
- Last Updated 07/16/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1821432899
Products in Payments
- DUPIXENT (Biological) $1,692
- TREMFYA (Drug) $1,520
- SKYRIZI (Biological) $1,176
- Otezla (Drug) $743.58
- VTAMA (Drug) $736.23
- OPZELURA (Drug) $706.59
- ILUMYA (Biological) $644.62
- COSENTYX (Drug) $582.04
- RINVOQ (Biological) $492.42
- Cimzia (Drug) $437.58
- Sotyktu (Drug) $415.51
- TALTZ (Drug) $411.44
- EUCRISA (Drug) $396.61
- COSENTYX (Biological) $365.11
- ZILXI (Drug) $352.31
- HUMIRA (Biological) $320.86
- ADBRY (Biological) $316.15
- ARAZLO (Drug) $309.31
- Bimzelx (Biological) $285.90
- Ilumya (Biological) $253.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Columbia
Marcy Markes, Aprn, Fnp-Bc, Ae-C, APRN, FNP-BC, AE-C
Family — Payments: $78,195
Family $78,195
Mary Williams, Aprn, APRN
Family — Payments: $67,362
Family $67,362
Caroline Wettengel, Crnp, CRNP
Family — Payments: $24,454
Family $24,454
Mrs. Sara Krafft, Crna, CRNA
Family — Payments: $13,758
Family $13,758
Timothy Dickey, Fnp-C, FNP-C
Family — Payments: $11,819
Family $11,819
Mrs. Katherine Coleman, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $11,724
Family $11,724